Thatte H S, Bridges K R, Golan D E
Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115.
J Cell Physiol. 1994 Aug;160(2):345-57. doi: 10.1002/jcp.1041600216.
We used quantitative fluorescence microscopy and fluorescence photobleaching recovery techniques to investigate the translational movement, cell surface expression, and endocytosis of transferrin receptors in K562 human erythroleukemia cells. Receptors were labeled with fluorescein-conjugated transferrin (FITC-Tf). Coordinated decreases in surface fluorescence counts, the photobleaching parameter K, and transferrin receptor fractional mobility were observed as FITC-Tf was cleared from the cell surface by receptor-mediated endocytosis. Based on the kinetics of decrease in these parameters, first order rate constants for FITC-Tf uptake at 37 degrees C and 21 degrees C were calculated to be 0.10-0.15 min-1 and 0.02-0.03 min, respectively. K562 cells were treated with colchicine or vinblastine to investigate the role of microtubules in transferrin receptor movement and endocytosis. Treatment of cells for 1 hr with a microtubule inhibitor prevented transferrin receptor endocytosis but had no effect on the translational mobility of cell surface receptors. In contrast, drug treatment for 3 hr caused translational immobilization of cell surface receptors as well as inhibition of endocytosis. These effects were not produced by beta-lumicolchicine, an inactive colchicine analog, or by cytochalasin, a microfilament inhibitor. The effect of microtubule inhibitors on transferrin receptor mobility was reversed by pretreating cells with taxol, a microtubule-stabilizing agent. Microtubule inhibitors had no effect on the translational mobility of cell surface glycophorins or phospholipids, indicating that intact microtubules were not required for translational movement of these molecules. We conclude that the translational movement of cell surface transferrin receptors is directed by a subpopulation of relatively drug-resistant microtubules. In contrast, transferrin receptor endocytosis depends on a subpopulation of microtubules that is relatively sensitive to the action of inhibitors. These results appear to demonstrate at least two functional roles for microtubules in receptor-mediated transferrin uptake in K562 cells.
我们运用定量荧光显微镜和荧光光漂白恢复技术,研究了K562人红白血病细胞中转铁蛋白受体的平移运动、细胞表面表达及内吞作用。受体用荧光素偶联的转铁蛋白(FITC-Tf)进行标记。当FITC-Tf通过受体介导的内吞作用从细胞表面清除时,观察到表面荧光计数、光漂白参数K以及转铁蛋白受体分数迁移率的协同下降。根据这些参数下降的动力学,计算出37℃和21℃时FITC-Tf摄取的一级速率常数分别为0.10 - 0.15 min⁻¹和0.02 - 0.03 min⁻¹。用秋水仙碱或长春花碱处理K562细胞,以研究微管在转铁蛋白受体运动和内吞作用中的作用。用微管抑制剂处理细胞1小时可阻止转铁蛋白受体的内吞作用,但对细胞表面受体的平移迁移率没有影响。相反,药物处理3小时会导致细胞表面受体的平移固定以及内吞作用的抑制。这些效应不是由无活性的秋水仙碱类似物β-光秋水仙碱或微丝抑制剂细胞松弛素产生的。用微管稳定剂紫杉醇预处理细胞可逆转微管抑制剂对转铁蛋白受体迁移率的影响。微管抑制剂对细胞表面血型糖蛋白或磷脂的平移迁移率没有影响,表明这些分子的平移运动不需要完整的微管。我们得出结论,细胞表面转铁蛋白受体的平移运动由相对耐药的微管子群体引导。相比之下,转铁蛋白受体的内吞作用依赖于对抑制剂作用相对敏感的微管子群体。这些结果似乎证明了微管在K562细胞中受体介导的转铁蛋白摄取中至少有两种功能作用。